• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生产针对志贺样毒素 (stx) 的蛋黄抗体 (IgY) 及其在小鼠中的预防效果评价。

Production of egg yolk antibody (IgY) against shiga-like toxin (stx) and evaluation of its prophylaxis potency in mice.

机构信息

Department of Bacteriology and Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Biological Research Center, Faculty of Science, Imam Hossein University, Tehran, Iran.

出版信息

Microb Pathog. 2020 Aug;145:104199. doi: 10.1016/j.micpath.2020.104199. Epub 2020 Apr 19.

DOI:10.1016/j.micpath.2020.104199
PMID:32320733
Abstract

OBJECTIVE

Enterohemorrhagic Escherichia coli (E. coli O157: H7) is an enteric pathogen, transmitted through contaminated water and food. Pathogenic factors include bacterial adhesion, invasion of intestinal epithelial and epithelium cells. The pathogenicity of EHEC is due to the production of Shiga-like toxin (Stx). This toxin binds to the ribosome and inhibits the synthesis of proteins. EHEC causes hemorrhagic colitis (HC) and hemolytic uremic syndrome (HUS). The EHEC treatment with antibiotics leads to resistance. The best way to solve this problem is to use specific antibodies and prophylaxis. Egg yolk antibody (IgY) is a suitable method for prophylaxis. Hence, the aim of this study was to investigate the production of IgY against Stx toxin and its prophylaxis.

RESULT

The produced antibodies were confirmed by SDS-PAGE and ELISA. IgY was obtained at a concentration of about 5 mg/ml (30 mg of each egg) and a purity of more than 90%. Toxin and antibody challenge was performed in mice. The obtained IgY was able to neutralize the effect of Stx at 2 mg/mice.

CONCLUSION

This challenge showed that an antibody produced with an acceptable percentage was able to neutralize the effect of Stx.

摘要

目的

肠出血性大肠杆菌(E. coli O157:H7)是一种肠道病原体,通过污染的水和食物传播。致病因素包括细菌黏附、侵袭肠道上皮细胞和上皮细胞。EHEC 的致病性是由于产生志贺样毒素(Stx)。这种毒素与核糖体结合并抑制蛋白质的合成。EHEC 引起出血性结肠炎(HC)和溶血性尿毒症综合征(HUS)。EHEC 对抗生素的治疗产生耐药性。解决这个问题的最好方法是使用特异性抗体和预防措施。卵黄抗体(IgY)是一种合适的预防方法。因此,本研究的目的是研究针对 Stx 毒素的 IgY 的产生及其预防作用。

结果

通过 SDS-PAGE 和 ELISA 确认了产生的抗体。IgY 的浓度约为 5mg/ml(每个鸡蛋 30mg),纯度超过 90%。在小鼠中进行了毒素和抗体的挑战。获得的 IgY 能够中和 2mg/mice 剂量的 Stx 的作用。

结论

这项挑战表明,用可接受的百分比产生的抗体能够中和 Stx 的作用。

相似文献

1
Production of egg yolk antibody (IgY) against shiga-like toxin (stx) and evaluation of its prophylaxis potency in mice.生产针对志贺样毒素 (stx) 的蛋黄抗体 (IgY) 及其在小鼠中的预防效果评价。
Microb Pathog. 2020 Aug;145:104199. doi: 10.1016/j.micpath.2020.104199. Epub 2020 Apr 19.
2
Detection of Shiga toxin-producing Escherichia coli by sandwich enzyme-linked immunosorbent assay using chicken egg yolk IgY antibodies.夹心酶联免疫吸附试验用鸡卵黄免疫球蛋白 Y 抗体检测产志贺毒素大肠杆菌。
Front Cell Infect Microbiol. 2012 Jun 18;2:84. doi: 10.3389/fcimb.2012.00084. eCollection 2012.
3
Specific egg yolk immunoglobulin as a new preventive approach for Shiga-toxin-mediated diseases.特异性卵黄免疫球蛋白作为一种新的预防志贺毒素介导疾病的方法。
PLoS One. 2011;6(10):e26526. doi: 10.1371/journal.pone.0026526. Epub 2011 Oct 19.
4
Antibodies anti-Shiga toxin 2 B subunit from chicken egg yolk: isolation, purification and neutralization efficacy.鸡卵黄来源的抗志贺毒素 2B 亚单位抗体:分离、纯化和中和效力。
Toxicon. 2011 Sep 15;58(4):380-8. doi: 10.1016/j.toxicon.2011.07.009. Epub 2011 Jul 22.
5
Shiga toxin in enterohemorrhagic E.coli: regulation and novel anti-virulence strategies.产志贺毒素大肠埃希菌中的志贺毒素:调控与新型抗毒力策略。
Front Cell Infect Microbiol. 2012 Jun 7;2:81. doi: 10.3389/fcimb.2012.00081. eCollection 2012.
6
Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7.益生菌大肠杆菌 Nissle 1917 对 O104:H4 和 O157:H7 血清型肠出血性大肠杆菌菌株的拮抗作用。
Int J Med Microbiol. 2013 Jan;303(1):1-8. doi: 10.1016/j.ijmm.2012.11.006. Epub 2013 Jan 10.
7
Efficacy of a recombinant Intimin, EspB and Shiga toxin 2B vaccine in calves experimentally challenged with Escherichia coli O157:H7.重组 Intimin、EspB 和志贺毒素 2B 疫苗对大肠杆菌 O157:H7 攻毒犊牛的效力。
Vaccine. 2018 Jun 22;36(27):3949-3959. doi: 10.1016/j.vaccine.2018.05.059. Epub 2018 May 26.
8
Promoter sequence of Shiga toxin 2 (Stx2) is recognized in vivo, leading to production of biologically active Stx2.志贺毒素 2(Stx2)启动子序列在体内被识别,导致具有生物活性的 Stx2 的产生。
mBio. 2013 Oct 1;4(5):e00501-13. doi: 10.1128/mBio.00501-13.
9
Production of egg yolk antibody (IgY) against a chimeric protein containing IpaD, StxB, and TolC antigens from Shigella: An investigation of its prophylactic effects against Shiga toxin (Stx) and and .抗包含志贺氏菌IpaD、StxB和TolC抗原的嵌合蛋白的蛋黄抗体(IgY)的制备:对其抗志贺毒素(Stx)预防作用的研究 以及 。 (注:原文结尾处不完整,翻译时尽量忠实原文表述)
Heliyon. 2024 Feb 16;10(4):e26361. doi: 10.1016/j.heliyon.2024.e26361. eCollection 2024 Feb 29.
10
Preservation of protective capacity of hyperimmune anti-Stx2 bovine colostrum against enterohemorrhagic Escherichia coli O157:H7 pathogenicity after pasteurization and spray-drying processes.巴氏杀菌和喷雾干燥工艺后,高免抗 Stx2 牛初乳对肠出血性大肠杆菌 O157:H7 致病性的保护能力的保持。
J Dairy Sci. 2021 May;104(5):5229-5238. doi: 10.3168/jds.2020-19709. Epub 2021 Mar 6.

引用本文的文献

1
Therapeutic efficacy of SipD/LptD-specific IgY entrapped in alginate nanoparticles against Typhimurium infection.包封在海藻酸钠纳米颗粒中的SipD/LptD特异性卵黄抗体对鼠伤寒沙门氏菌感染的治疗效果。
Heliyon. 2024 Oct 24;10(21):e39650. doi: 10.1016/j.heliyon.2024.e39650. eCollection 2024 Nov 15.
2
Development of protective egg yolk immunoglobulins (IgY) targeting CfaB, LTB, and EtpA recombinant proteins of Enterotoxigenic Escherichia coli (ETEC) for inhibiting toxin activity and bacterial adherence.开发针对产肠毒素大肠杆菌(ETEC)的CfaB、LTB和EtpA重组蛋白的保护性蛋黄免疫球蛋白(IgY),以抑制毒素活性和细菌黏附。
Braz J Microbiol. 2025 Mar;56(1):403-413. doi: 10.1007/s42770-024-01554-0. Epub 2024 Nov 6.
3
Characterization of anti-soybean agglutinin (SBA) IgY antibodies: a new strategy for neutralization of the detrimental biological activity of SBA.
抗大豆凝集素(SBA)IgY抗体的特性:一种中和SBA有害生物活性的新策略。
Front Vet Sci. 2024 Apr 12;11:1382510. doi: 10.3389/fvets.2024.1382510. eCollection 2024.
4
Production of egg yolk antibody (IgY) against a chimeric protein containing IpaD, StxB, and TolC antigens from Shigella: An investigation of its prophylactic effects against Shiga toxin (Stx) and and .抗包含志贺氏菌IpaD、StxB和TolC抗原的嵌合蛋白的蛋黄抗体(IgY)的制备:对其抗志贺毒素(Stx)预防作用的研究 以及 。 (注:原文结尾处不完整,翻译时尽量忠实原文表述)
Heliyon. 2024 Feb 16;10(4):e26361. doi: 10.1016/j.heliyon.2024.e26361. eCollection 2024 Feb 29.
5
Production of Egg Yolk Antibody (IgY) Against O1: Protective Effect in Mice.抗O1蛋黄抗体(IgY)的制备:对小鼠的保护作用
Avicenna J Med Biotechnol. 2023 Oct-Dec;15(4):239-244. doi: 10.18502/ajmb.v15i4.13497.
6
IgYs: on her majesty's secret service.伊格斯:为女王陛下服务。
Front Immunol. 2023 Jun 12;14:1199427. doi: 10.3389/fimmu.2023.1199427. eCollection 2023.
7
Evaluation of PLGA-Encapsulated Recombinant GroEL of immune Responses Against Enterohaemorrhagic and Enteropathogenic .聚乳酸-羟基乙酸共聚物包裹的重组伴侣蛋白GroEL对肠出血性和肠致病性大肠杆菌免疫反应的评估
Avicenna J Med Biotechnol. 2022 Oct-Dec;14(4):294-302.
8
An Design, Expression and Purification of a Chimeric Protein as an Immunogen Candidate Consisting of IpaD, StxB, and TolC Proteins from spp.一种由来自[物种名称]的IpaD、StxB和TolC蛋白组成的嵌合蛋白作为免疫原候选物的设计、表达与纯化
Avicenna J Med Biotechnol. 2022 Jul-Sep;14(3):247-258. doi: 10.18502/ajmb.v14i3.9832.
9
Therapeutic Antibodies Against Shiga Toxins: Trends and Perspectives.抗志贺毒素的治疗性抗体:趋势与展望。
Front Cell Infect Microbiol. 2022 Feb 10;12:825856. doi: 10.3389/fcimb.2022.825856. eCollection 2022.
10
Microencapsulated phages show prolonged stability in gastrointestinal environments and high therapeutic efficiency to treat Escherichia coli O157:H7 infection.微囊化噬菌体在胃肠道环境中表现出延长的稳定性,并具有高效的治疗大肠杆菌 O157:H7 感染的疗效。
Vet Res. 2021 Sep 14;52(1):118. doi: 10.1186/s13567-021-00991-1.